Who to call at Mangoceuticals, and when
Fundz watches for the moments Mangoceuticals starts buying, and tells you who to reach.
- An alert the day Mangoceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Mangoceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Mangoceuticals. With Fundz connected, it knows.
Mangoceuticals Partners with T7X to Issue $10 Million in Series D Convertible Preferred Stock.
Contract Type
partnership
DallasOtherBiotechnologyHealth CareDietary SupplementsNutritionDescription
Mangoceuticals has partnered with T7X to sell up to $10 million of Series D Cumulative Convertible Preferred Stock priced at $10.00 per share, using the T7X blockchain platform. The offering aims to raise capital without immediate dilution to common shareholders, with conversion into common stock beginning three years after issuance at a premium price.
Quick answer
Mangoceuticals Partners with T7X to Issue $10 Million in Series D Convertible Preferred Stock. (November 12, 2026). Mangoceuticals is based in Dallas, Texas, United States.
- What agreement did Mangoceuticals announce on November 12, 2026?
- Mangoceuticals has partnered with T7X to sell up to $10 million of Series D Cumulative Convertible Preferred Stock priced at $10.00 per share, using the T7X blockchain platform. The offering aims to raise capital without immediate dilution to common shareholders, with conversion into common stock beginning three years after issuance at a premium price.
- What does Mangoceuticals do?
- MangoRX is a new men’s health and wellness company dedicated to developing, marketing, and selling a variety of men’s wellness products and services via a telemedicine platform that connects consumers to licensed...
- Where is Mangoceuticals based?
- Mangoceuticals is based in Dallas, Texas, United States.
- Which similar companies announced agreements around the same time?
- Lifespan Private Limited (October 27, 2026), HealthyCell (October 22, 2026), Opella (October 19, 2026) and United Wholesale Mortgage (November 12, 2026) also announced agreements within 45 days of Mangoceuticals.
Source: Fundz verified event record.
Other recent agreements in Dietary Supplements and Nutrition
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- Lifespan Private Limited extends brand ambassador contract with shooter Esha Singh to promote health and wellness. (October 27, 2026)
- Kate Hudson Partners with HealthyCell to Enhance Nutritional Supplementation Experience. (October 22, 2026)
- Opella and World Allergy Organization establish five-year partnership to enhance global allergy care. (October 19, 2026)
- UWM Expands Partnership with Bilt to Enhance Broker Experience and Customer Loyalty. (November 12, 2026)
- ChronicleBio and Prolong Pharmaceuticals Form Partnership to Develop PP-007 for Chronic Fatigue Syndrome Treatment. (November 12, 2026)
- Quantum Cyber N.V. Enters into Expanded Intellectual Property License Agreement with LightShift (November 12, 2026)
Agreement Insights
What this usually meansMangoceuticals signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.